Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice

International Journal of Cancer

Volumn 118, Issue 3, 2006, Pages 643-648

  Zhao, Xudong ^a,b   Ren, Weihua ^a   Yang, Wenjun ^c   Wang, Yi ^b   Kong, Hui ^b   Wang, Long ^b,d   Yan, Lanzhen ^b   Xu, Guojiang ^b   Fei, Jian ^b   Fu, Jiliang ^b   Zhang, Chenping ^c   Wang, Zhugang ^a,b,d,e  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b Shanghai Nan Fang Model Organism Research Center   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

catenin; Pleomorphic adenoma gene 1; Pleomorphic adenomas; Transgenic mice

Indexed keywords

BETA CATENIN; BETA GALACTOSIDASE; LUCIFERASE; MYC PROTEIN; RNA; TRANSCRIPTION FACTOR; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PLEOMORPHIC ADENOMA; PLEOMORPHIC ADENOMA GENE 1; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SALIVARY GLAND TUMOR; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

3T3 CELLS; ADENOMA, PLEOMORPHIC; ANIMALS; BETA CATENIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-MYC; SALIVARY GLAND NEOPLASMS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION; WNT PROTEINS;

EID: 30444458669     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21400     Document Type: Article

References (35)

1. Enlund F, Nordkvist A, Sahlin P, Mark J, Stenman G. Expression of PLAG1 and HMG1C proteins and fusion transcripts in radiation-associated pleomorphic adenomas. Int J Oncol 2002;20:713-6.
2. Kas K, Voz ML, Roijer E, Astrom AK, Meyen E, Stenman G, Van de Ven WJ. Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3:8)(p21;q12) translocations. Nat Genet 1997;15:170-4.
3. Voz ML, Astrom AK, Kas K, Mark J, Stenman G, Van de Ven WJ. The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter. Oncogene 1998;16:1409-16.
4. Astrom AK, Voz ML, Kas K, Roijer E, Wedell B, Mandahl N, Van de Ven W, Mark J, Stenman G. Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene. Cancer Res 1999;59:918-23.
5. Hibbard MK, Kozakewich HP, Dal Cin P, Sciot R, Tan X, Xiao S, Fletcher JA. PLAG1 fusion oncogenes in lipoblastoma. Cancer Res 2000;60:486972.
6. Astrom A, D'Amore ES, Sainati L, Panarello C, Morerio C, Mark J, Stenman G. Evidence of involvement of the PLAG1 gene in lipoblastomas. Int J Oncol 2000;16:1107-10.
7. Zatkova A, Rouillard JM, Hartmann W, Lamb BJ, Kuick R, Eckart M, von Schweinitz D, Koch A, Fonatsch C, Pietsch T, Hanash SM, Wimmer K. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. Genes Chromosomes Cancer 2004;39:126-37.
8. Landrette SF, Kuo YH, Hensen K, Khosrovani B, Perrat PN, Van de Ven WJ, Delwel R, Castilla LH. Plag1 and Plag12 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood 2005;105:2900-7.
9. Hensen K, Van Vatckenborgh IC, Kas K, Van de Ven WJ, Voz ML. The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities. Cancer Res 2002;62:1510-7.
10. Voz ML, Agten NS, Van de Ven WJ, Kas K. PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II. Cancer Res 2000;60:106-13.
11. Zhao XD, Yang WJ, Wang L, Kong H, Ren WH, Zhang M, Fei J, Zhang CP, Wang ZG. Development of salivary gland tumors in pleomorphic adenoma gene 1 transgenic mice. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003;2:390-5.
12. Xie W, Paterson AJ, Chin E, Nabell LM, Kudlow JE. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol Endocrinol 1997;11:1766-81.
13. Pierce DF Jr, Johnson MD, Matsui Y, Robinson SD, Gold LI, Purchio AF, Daniel CW, Hogan BL, Moses HL. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Genes Dev 1993;7:2308-17.
14. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 1987;49:465-75.
15. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988;55:619-25.
16. Jhappan C, Gallahan D, Stahle C, Chu E, Smith GH, Merlino G, Callahan R. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev 1992;6:345-55.
17. Daphna-Iken D, Shankar DB, Lawshe A, Ornitz DM, Shackleford GM, MacArthur CA. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Oncogene 1998;17:2711-7.
18. Bouchard L, Lamarre L, Tremblay PJ, Jolicoeur P. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 1989;57:931-6.
19. Lucchini F, Sacco MG, Hu N, Villa A, Brown J, Cesano L, Mangiarini L, Rindi G, Kindl S, Sessa F. Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTV-Neu transgenic mice. Cancer Lett 1992;64:203-9.
20. Furth PA, Li M, Hennighausen L. Studying development of disease through temporally controlled gene expression in the salivary gland. Ann NY Acad Sci 1998;842:181-7.
21. Cardiff RD, Sinn E, Muller W, Leder P. Transgenic oncogene mice: tumor phenotype predicts genotype. Am J Pathol 1991;139:495-501.
22. Dardick I, Ho J, Paulus M, Mellon PL, Mirels L. Submandibular gland adenocarcinoma of intercalated duct origin in Smgb-Tag mice. Lab Invest 2000;80:1657-70.
23. Rooman R, Koster G, Bloemen R, Gresnigt R, van Buul-Offers SC. The effect of dexamethasone on body and organ growth of normal and IGF-II-transgenic mice. J Endocrinol 1999;163:543-52.
24. Toretsky JA, Helman LJ. Involvement of IGF-II in human cancer. J Endocrinol 1996;149:367-72.
25. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR, Feinberg AP. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003;299:1753-5.
26. Sachdev D, Yee D. The IGF system and breast cancer. Endocr Relat Cancer 2001;8:197-209.
27. Butterwith SC, Goddard C. Regulation of DNA synthesis in chicken adipocyte precursor cells by insulin-like growth factors, platelet-derived growth factor and transforming growth factor-beta. J Endocrinol 1991;131:203-9.
28. Scharf JG, Dombrowski F, Ramadori G. The IGF axis and hepatocarcinogenesis. Mol Pathol 2001;54:138-44.
29. Moorehead RA, Fata JE, Johnson MB, Khokha R. Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice. Cell Death Differ 2001;8:16-29.
30. Moorehead RA, Sanchez OH, Baldwin RM, Khokha R. Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma. Oncogene 2003;22:853-7.
31. Voz ML, Mathys J, Hensen K, Pendeville H, Van Valckenborgh I, Van Huffel C, Chavez M, Van Damme B, De Moor B, Moreau Y, Van de Ven WJ. Microarray screening for target genes of the proto-oncogene PLAG1. Oncogene 2004;23:179-91.
32. Peifer M. Beta-catenin as oncogene: the smoking gun. Science 1997;275:1752-3.
33. Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science 2002;296:1644-6.
34. Saito T, Oda Y, Kawaguchi K, Tanaka K, Matsuda S, Tamiya S, Iwamoto Y, Tsuneyoshi M. Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan polymerase chain reaction. Lab Invest 2002;82:97-103.
35. Morali OG, Delmas V, Moore R, Jeanney C, Thiery JP, Larue L. IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 2001;20:4942-50.